North Star Investment Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$689 Hold
346
– – ﹤0.01% 1594
2026
Q1
$439 Buy
+346
New +$651 ﹤0.01% 1639

Other funds holding HCAT

North Star Investment Management's HCAT Position: Q2 2026 in Review

North Star Investment Management held its Health Catalyst (HCAT) position steady in Q2 2026 at 346 shares worth $689. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

North Star Investment Management first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • North Star Investment Management held 346 shares of Health Catalyst worth $689 as of Q2 2026.
  • North Star Investment Management left its Health Catalyst share count unchanged in Q2 2026.
  • Health Catalyst made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1594 holding.
  • North Star Investment Management first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.